Combination of olfactory test and substantia nigra transcranial sonopraphy in the differential diagnosis of Parkinson's disease: A pilot study from China

Translational Neurodegeneration

Volumn 1, Issue , 2012, Pages

  Chen, Wei ^a   Tan, Yu Yan ^a   Hu, Yun Yun ^a   Zhan, Wei Wei ^a   Wu, Li ^a   Lou, Yue ^a   Wang, Xi ^a   Zhou, Yi ^a   Huang, Pei ^a   Gao, Yuan ^a   Xiao, Qin ^a   Chen, Sheng Di ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Hyposmia; Parkinson's disease; Transcranial sonography

Indexed keywords

ADULT; ARTICLE; CHINA; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOGRAPHY; ESSENTIAL TREMOR; FEMALE; HUMAN; HYPOSMIA; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MALE; OLFACTORY DISCRIMINATION; PARKINSON DISEASE; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMELLING;

EID: 84883602121     PISSN: None     EISSN: 20479158     Source Type: Journal    
DOI: 10.1186/2047-9158-1-25     Document Type: Article

References (20)

1. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol 2006, 5:75-86. 10.1016/S1474-4422(05)70285-4, 16361025.
2. Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008, 63:167-173. 10.1002/ana.21291, 18067173.
3. Walter U, Niehaus L, Probst T, et al. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003, 60:74-77. 10.1212/WNL.60.1.74, 12525721.
4. Barresi M, Ciurleo R, Giacoppo S, et al. Evaluation of olfactory dysfunction in neurodegenerative diseases. J Neurol Sci 2012, 323:16-24. 10.1016/j.jns.2012.08.028, 23010543.
5. Okawa M, Miwa H, Kajimoto Y, et al. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations. Intern Med 2007, 46:1527-1531. 10.2169/internalmedicine.46.0271, 17878638.
6. Izawa MO, Miwa H, Kajimoto Y, et al. Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease. Eur J Neurol 2012, 19:411-416. 10.1111/j.1468-1331.2011.03533.x, 21978091.
7. Busse K, Heilmann R, Kleinschmidt S, et al. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease. J Neurol Neurosurg Psychiatry 2012, 83:441-447. 10.1136/jnnp-2011-301719, 22362921.
8. Chen W, Chen S, Kang WY, et al. Application of odor identification test in Parkinson's disease in China: a matched case-control study. J Neurol Sci 2012, 316:47-50. 10.1016/j.jns.2012.01.033, 22364958.
9. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992, 55:181-184. 10.1136/jnnp.55.3.181, 1014720, 1564476.
10. Bain P, Brin M, Deuschl G, et al. Criteria for the diagnosis of essential tremor. Neurology 2000, 54:S7.
11. Zhang MY, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990, 27:428-437. 10.1002/ana.410270412, 2353798.
12. Sengoku R, Saito Y, Ikemura M, et al. Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 2008, 67:1072-1083. 10.1097/NEN.0b013e31818b4126, 18957894.
13. Beach TG, White CL, Hladik CL, et al. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 2009, 117:169-174. 10.1007/s00401-008-0450-7, 2631085, 18982334.
14. Berg D, Grote C, Rausch WD, et al. Iron accumulation in the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 1999, 25:901-904. 10.1016/S0301-5629(99)00046-0, 10461717.
15. Berg D, Roggendorf W, Schroder U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002, 59:999-1005. 10.1001/archneur.59.6.999, 12056937.
16. Baba T, Kikuchi A, Hirayama K, et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain 2012, 135:161-169. 10.1093/brain/awr321, 22287381.
17. Berg D, Merz B, Reiners K, et al. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005, 20:383-385. 10.1002/mds.20311, 15486999.
18. Stoessl AJ. Neuroimaging in the early diagnosis of neurodegenerative disease. Transl Neurodegener 2012, 1:5. 10.1186/2047-9158-1-5, 3506998, 23211024.
19. Zhang YC, Fang JC, Sheng YJ, et al. The study of transcranial sonography on Parkinson's disease and essential tremor. Chin J Neurol 2011, 44:590-593.
20. Iwanami M, Miyamoto T, Miyamoto M, et al. Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder. Sleep Med 2010, 11:361-365. 10.1016/j.sleep.2009.12.006, 20223708.